We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Health body’s concern reflects heightened vigilance over signs of disease outbreaks since Covid pandemic
Vaccine recipient claims he suffered side effect of severe blood clot
German group says prospective blockbuster asundexian failed to demonstrate efficacy
A new crop of weight-loss drugs is disrupting markets as well as transforming waistlines
Study shows potential of technology to improve and speed up medical diagnoses
Regulator authorises treatment for sickle cell disease and beta thalassaemia
T-Therapeutics hopes to use genetically engineered rodents and machine learning to discover drugs
Anjana Ahuja selects her must-read titles
Covid may have abated, but emerging diseases and new drug categories are keeping the analytics firm busy
With real meat facing real problems, investors should cut back their exposure
Wegovy found to have ‘quite profound’ effect on reducing risk of heart attacks, says pharma group
Anglo-Swedish drugmaker’s oncology and rare disease medication sales offset waning demand for Covid jabs
US and UK regulators say diabetes medication showed ‘significant’ weight loss benefits
German group slashes guidance by €1bn and reduces spending as it expects fewer first vaccine doses and lower boosting
Findings show need to mitigate growing risks posed by animal-to-human pathogens such as coronaviruses
Findings could boost development of medical technology such as brain-machine interfaces
Biotech blames weaker US sales after lowering full-year forecast
Danish group has expanded manufacturing capacity but says demand will continue to outstrip supply
First jab for respiratory syncytial virus powers sales at UK drugmaker
Further research on its underlying causes and preventive action is essential
Domestically made products like syringes currently cost more than those produced in China
Emerging research is challenging a widely held belief that new cases of the condition will rise exponentially as people live longer
UK Biobank’s records of 500,000 people promise breakthroughs in diseases and ageing
Pioneering medicines developed by Eisai and Eli Lilly shown to be more effective when taken earlier
Swiss pharma group acquires rights to develop and manufacture bowel disease treatment
International Edition
